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Ligand-Mediated Transcription Elongation Control
Using Triplex-Based Padlock Oligonucleotides
DNA interactions can interfere with gene expression in
cells [3, 4]. There are many fewer reports of transcription
inhibition by TFOs that bind downstream of the tran-
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Muse´um National d’Histoire Naturelle scription initiation site. Cell-free transcription assays
have shown that micromolar amounts of TFOs can par-INSERM U565, CNRS UMR5153
43 rue Cuvier tially inhibit the elongation of transcription by prokary-
otic RNA polymerases, such as SP6, T3, or T7 RNA75231 Paris, Cedex 05
France polymerases [5, 6]. By combining the use of a TFO-inter-
calator conjugate and a triple-helix-stabilizing agent, up
to 60% inhibition of SP6 RNA polymerase was achieved
[6]. Elongation by eukaryotic RNA polymerases was in-Summary
hibited more efficiently in cell-free transcription assays
(up to 100%), probably because these enzymes are lessTriplex-forming oligonucleotides (TFOs) provide use-
processive than prokaryotic RNA polymerases [6–8]. Allful tools for the artificial regulation of gene expression
these studies involved chemically modified oligodeoxy-at the transcriptional level. They can become topologi-
nucleotides. The most efficient way of blocking elonga-cally linked to their DNA target upon circularization,
tion by an RNA polymerase was to crosslink the TFO tothereby forming very stable triple helical structures.
its DNA target using a TFO-psoralen conjugate, espe-These “padlock oligonucleotides” are able to interfere
cially in cells [9–11].with transcription elongation when their target site is
We have recently shown that a TFO could be circular-located in the transcribed region of a gene. In vitro
ized around its target, using a short template oligonucle-transcription experiments showed that a bacterial
otide and T4 DNA ligase, yielding a so-called padlockRNA polymerase was stopped at the site of triple-helix
oligonucleotide [12]. These padlock oligonucleotidesformation, whereas expression of a reporter gene was
may have various applications as a double-strandedinhibited in live cells. In both cases, the padlock oligo-
DNA labeling method and in gene therapy [13–15]. Thenucleotide was more efficient at inhibiting transcrip-
effects of the padlock oligonucleotide on DNA-proteintion elongation than a linear TFO, and the inhibition
interactions have been investigated using a restrictionwas observed only in the presence of a triplex stabiliz-
enzyme cleavage assay [16]. We have shown that undering agent. These results provide new insights into the
conditions where the triple helix was stable, the padlockligand-modulated locking of padlock oligonucleotides
oligonucleotide inhibits cleavage by the restriction en-around their DNA target.
zyme, and that removal of the triplex stabilizing agent
was sufficient to restore the cleavage, which suggestsIntroduction
that the padlock oligonucleotide could be displaced
from its binding site.Triplex-forming oligonucleotides (TFOs) represent an at-
In this paper, we have examined the effects of padlocktractive tool for the sequence-specific control of gene
oligonucleotides on transcription elongation in a cell-expression at the transcriptional level, in the so-called
free system using a bacterial RNA polymerase, and in“antigene” strategy [1]. They can bind to the major
a cultured mammalian cell line using a reporter gene.groove of the DNA double-helix by formation of specific
We showed that in both systems, the padlock oligonu-hydrogen bonds between the bases of the TFO and the
cleotide was able to strongly inhibit transcription elon-purine bases within the double-stranded DNA target
gation, under conditions where a linear TFO had a verysequence. The parameters that govern triple-helix for-
limited efficiency. This effect was dependent on themation and stability have been extensively studied [2].
presence of a triplex stabilizing agent.In cells, the activity of TFOs can be compromised by
the sensitivity of oligonucleotides toward intracellular
nucleases, as well as by the stability of triple helical
Resultscomplexes. The ionic conditions that prevail in the intra-
cellular environnement are different from those which
Inhibition of a Bacterial RNA Polymerasefavor triple-helix formation in vitro. Chemical modifica-
To examine the ability of a padlock oligonucleotide totions of deoxyoligonucleotides can help overcome some
inhibit transcription elongation, we first chose to useof these constraints [2].
a cell-free transcription assay. The pGA2 plasmid wasTFOs have been shown to compete with DNA binding
obtained by insertion of a triplex target sequence in theproteins in vitro, and inhibition of transcription factor-
multi-cloning-site (mcs) of pBluescript SK (Figure 1)
[16]. This mcs is located between promoters for two
*Correspondence: escude@mnhn.fr commonly used prokaryotic RNA polymerases, the bac-
1These authors contributed equally to this work. teriophage T3 and T7 RNA polymerases. We had pre-2 Present address: INSERM U 533, Faculte´ de Me´decine, 1 rue Gas-
viously shown that a TFO could be efficiently catenatedton Veil BP 53508, 44035 Nantes, Cedex 1, France.
to the pGA2 plasmid and was able to inhibit cleavage3 Present address: ANOSYS Inc., 1014 Hamilton Court, Menlo Park,
California 94025. of the plasmid by the restriction endonuclease EcoNI
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Figure 2. Analysis of T3 RNA Polymerase Elongation by Denaturing
Gel Electrophoresis
In vitro transcription was carried out as described in the Experimen-
tal Procedures section and above the gel. The circularization reac-
tion was carried out in the presence of the template oligonucleotide
and ligase, before spermidine precipitation (lanes 3 and 4). In lane
5 and 6, the pGA2 plasmid had been linearized with the indicated
enzymes. In lanes 7 and 8, the ligase had been omitted in the circu-
larization reaction, but the plasmid had been purified as in lanes 3
and 4. In lanes 9 and 10, the plasmid was incubated with the linear
TFO (100 nM) before the transcription reaction was started. No
template or ligase was added in these last samples.
precipitation of the plasmid in the presence of sper-
midine.Figure 1. Description of the Chemicals, Plasmid, and Oligonucleo-
The yield of padlock attachment was first measuredtides Used in the In Vitro Transcription Assay
using the previously described gel shift assay [13].(A) Chemical structure of BQQ. (B) The 59-mer oligonucleotide TFO1
Briefly, the plasmid was treated by the restriction en-can form a triple helix by binding to an 18 bp oligopyrimidine•
oligopurine target sequence, located in the multi-cloning-site (mcs) zyme PvuII, which can cleave the plasmid at two sites
of the pBluescript SK plasmid, downstream from a T3 RNA poly- located on both sides of the mcs, 511 bp from each
merase promoter. The extremities of TFO1 can hybridize to the other. Attachment of the padlock oligonucleotide re-
17-mer oligonucleotide, thereby allowing its circularization by an sulted in a band shift of the shortest restriction fragment.
enzymatic ligation. The sites for the restriction enzymes PvuII, BglII,
The yield of padlock formation was estimated to be 90%and EcoNI are also indicated.
(not shown).
In vitro transcription reactions were then conducted
with unmodified and padlock-modified plasmids, both[16]. This inhibition was relieved upon removal of the
triplex stabilizing agent. The 5-phosphorylated TFO in the absence and presence of BQQ (Figure 2). The
intact circular plasmid was used in order to preservewas added in excess to the pGA2 plasmid in the pres-
ence of the triple-helix-specific ligand BQQ, and padlock the topological link between the plasmid and the TFO.
Labeled transcripts were analyzed by denaturing poly-formation was achieved by hybridizing the 3- and 5-
ends of the TFO to a 17-mer template oligonucleotide, acrylamide gel electrophoresis. In vitro transcription
carried out on the supercoiled pGA2 plasmid led to theand then adding T4 DNA ligase and incubating at 37C
for 1 hr. The mixture had to be heated and slowly cooled formation of a long transcript, which migrated very high
in the gel (Figure 2, lane 1). Only a few shorter transcriptsto allow for triple-helix formation and template hybrid-
ization in a precircularization complex, before addition were also observed, which are likely due to pausing of
the RNA polymerase. Addition of BQQ to the plasmidof the ligase. Removal of the TFO in excess and of
the triplex-stabilizing agent was achieved by selective had no effect on the pattern and quantity of transcription
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Figure 3. TFO inhibition on T3 RNA Polymerase Elongation
The normalized amount of long transcripts is presented in the pres-
ence (white bars) and absence (gray bars) of BQQ, for the plasmid
alone (1), for the plasmid in the presence of the linear TFO (2), and
for the padlock-modified plasmid (3). The normalization is carried
out with respect to the unmodified plasmid in the absence of BQQ.
This particular experiment is representative of three different experi-
ments.
products (lane 2). When the padlock-modified plasmid
was transcribed in the absence of BQQ (lane 3), the
products and yields were the same as with the non-
modified plasmid (lane 1). When both the padlock oligo-
nucleotide and BQQ were present (lane 4), the amount
of fully elongated transcript decreased by approximately
Figure 4. Description of the Plasmid and Oligonucleotides Used in
80% (Figure 3), while the appearence of a short band the Cellular Experiments
could be detected in the gel (see arrow on Figure 2). Sequences of the 50-mer TFO2 and the 17-mer template are shown.
The length of this band was analyzed by comparing it The 50-mer oligonucleotide can form a triple helix by binding to a
to the size of transcription products obtained with a 16 bp oligopyrimidine•oligopurine target sequence, located in the
transcribed region of the Renilla luciferase gene. The sites for theplasmid previously linearized with either BglII (Lane 6)
restriction enzymes AflIII and XmnI are also indicated.or EcoNI (lane 5), which cut the plasmid on both sides
of the oligopyrimidine•oligopurine sequence used for
triplex formation (see Figure 1). The aborted transcript found an appropriate sequence in the Renilla luciferase
was slightly longer than that obtained with the BglII gene on the pRLCMV plasmid (Promega). The 16-bp
digested plasmid, which suggests that the RNA poly- oligopyrimidine•oligopurine sequence was located be-
merase was blocked by the padlock oligonucleotide tween position 498 and 513 downstream of the start
bound to its expected target site. Transcription reac- site for transcription of the Renilla Luciferase reporter
tions were also conducted with pGA2 plasmid that had gene. TFO2 was designed to bind to this sequence and
been treated like the padlock-modified plasmid, but to form a triple helix made of T.AxT and C.GxG triplets
without the ligase in the reaction. No inhibition of tran- (Figure 4). Padlock formation was achieved in vitro as
scription could be observed (lane 8). Experiments car- described above. The yield of padlock attachment was
ried out in the presence of a 10-fold excess of the linear measured by a gel shift assay using XmnI and AflIII as
TFO showed a very weak band at the same position as restriction enzymes. About 90% of the 348 bp fragment
that observed with the padlock oligonucleotide, only in containing the target sequence was shifted, showing
the presence of BQQ (lane 10). The yield of the transcrip- that at least 90% of the plasmids were carrying a pad-
tion was decreased, but to a much lower extent than lock oligonucleotide at the expected site (Figure 5).
with the padlock oligonucleotide, as shown by quantifi- HeLa cells were cotransfected with both the pGL3c
cation of the long products (Figure 3). T3 RNA polymer- and pRLCMV plasmids. The pGL3c plasmid expresses
ase uses the strand containing the oligopurine sequence Firefly Luciferase under the control of an SV40 promoter,
as template strand. An in vitro transcription assay was and was cotransfected with pRLCMV in order to check
also performed using T7 RNA polymerase, which tran- for the influence of the presence of BQQ on transgene
scribes the other DNA strand. A similar arrest in tran- expression. Transfection was carried out with the non-
scription was observed (not shown). modified pRLCMV plasmid or the plasmid that has been
padlock-modified in vitro. These transfection were car-
ried out after or without addition of the triplex stabilizingInhibition of Transcription in Mammalian Cells
In order to investigate the effects of padlock oligonucle- agent BQQ. After 24 hr, the activity of both firefly and
Renilla luciferases was measured in cell extracts. Theotides on gene transcription in mammalian cells, we
looked for the presence of oligopyrimidine•oligopurine level of expression of Renilla luciferase was the same
in the absence and presence of BQQ when the non-sequences in commonly used reported genes, and
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Figure 5. Measurement of the Yield of Padlock Formation by a Gel- Figure 6. Specific Inhibition of Renilla Luciferase Expression by the
Shift Assay Padlock Oligonucleotide
Plasmids were treated in the presence (lanes 3 and 4) or absence Luciferase expression was measured 24 hr after cotransfection of
(lanes 1 and 2) of an excess of 5-phosphorylated TFO to allow for HeLa cells with both pGL3c and pRLCMV, and normalized for protein
padlock formation, as described in the Experimental Procedures content (n 3 in all cases). The expression of both Renilla luciferase
section. After purification by spermidine precipitation, samples were (white bars) and firefly luciferase (gray bars) is shown. (1) No plasmid.
heated in the presence (lanes 2 and 4) or absence (lanes 1 and 3) (2 and 3) Unmodified pGL3c and pRLCMV plasmids. (4 and 5) The
of 2 M BQQ and digested by XmnI and AflIII to produce a short pRLCMV plasmid was modified with the padlock oligonucleotide.
restriction fragment containing the target sequence. Samples were (6 and 7) The pRLCMV plasmid was treated as for padlock modifica-
then loaded on a 6% native polyacrylamide gel containing 10 mM tion, except that the DNA ligase was not added. (8 and 9) The
MgCl2, stained with SybrGreen I, and imaged with a camera. I, III, unmodified pRLCMV was prehybridized with the linear TFO (as indi-
and IV refer to the restriction fragments of 348, 978, and 2753 bp, cated by an asterisk) at a concentration of 1 M. The plasmids were
respectively. II corresponds to fragment I shifted by the presence prepared in the absence (2, 4, 6, and 8) or presence (3, 5, 7, and 9)
of a catenated padlock oligonucleotide. of BQQ. Each experiment was performed in triplicate. Vertical bars
represent the standard error of the mean of the three samples.
This panel shows one experiment representative of three different
experiments.modified pRLCMV plasmid was used (Figure 6, samples
2 and 3). Expression of Renilla luciferase was specifically
inhibited by 90% when the padlock-modified pRLCMV T3 RNA polymerase and led to the production of a trun-
plasmid was transfected after addition of BQQ (Figure cated RNA reflecting the position of the binding site for
6, sample 5). This inhibition was not observed when the the padlock oligonucleotide. This happened only in the
pRLCMV plasmid did not carry a padlock oligonucleo- presence of the triplex stabilizing agent BQQ, and inhibi-
tide (Figure 6, sample 3), when BQQ was omitted (Figure tion was much higher when the TFO had been circular-
6, sample 4), or when the plasmid had been treated as ized around its target compared with a linear TFO. These
for padlock attachment, but without the ligase in the results are consistent with previous reports showing
reaction (Figure 6, sample 7). Transfection was also con- that GT-rich TFOs that have been locked around their
ducted in the presence of linear TFO2 at a concentration target sequence in the presence of the triplex stabilizing
of up to 1 M in the transfection medium (Figure 6, agent BQQ can inhibit DNA cleavage by a restriction
sample 9). No significant decrease in Renilla luciferase endonuclease. We show here that this locking strategy
expression was observed. All these data suggest that results in complexes that are not displaced by highly
in the presence of BQQ the padlock oligonucleotide processive enzymes such as RNA polymerases.
was able to form a triple helical complex that inhibited The effects of padlock oligonucleotides on transcrip-
transcription of the Renilla luciferase gene specifically. tion elongation were also investigated in cells. Previous
The formation of this triple helical complex as well as experiments had shown that padlock oligonucleotides
gene expression inhibition was observed only in the did not interfere with gene expression when they were
presence of the triplex stabilizing agent BQQ. Moreover, targeted to sequences located outside of reporter genes
the padlock oligonucleotide was much more efficient [14]. We selected a 16 bp oligopyrimidine•oligopurine
than a linear oligonucleotide at blocking transcription sequence in the Renilla luciferase gene which appeared
elongation in this cellular transcription system. to be a good candidate for triple-helix formation. This
sequence was located 500 bp downstream from the
transcription start site. We designed a TFO that couldDiscussion
be efficiently catenated around this target sequence. A
very efficient inhibition of gene expression was observedThe purpose of this study was to investigate the effects
of padlock oligonucleotides on transcription elongation in cells for the plasmid that had been padlock modified
and incubated with the triplex stabilizing agent. Impor-by RNA polymerases. First, a cell-free transcription
assay showed that a padlock oligonucleotide that had tantly, it should be noted that excess unbound oligonu-
cleotides were removed in our assay. Expression of thebeen bound to a triplex site located downstream of the
start site was able to arrest transcription elongation by Renilla luciferase gene by the unmodified plasmid as
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well as expression of the firefly luciferase gene carried nucleotides, in an in vitro transcription assay with pro-
karyotic RNA polymerases [24] and in eukaryotic cellsby the cotransfected pGL3c plasmid were not affected
by the presence of BQQ. [25]. Synthetic polyamides made of N-methylimidazole
and N-methylpyrrole amino acids, which bind in the mi-The oligonucleotide that has been circularized around
its target appears to be much more efficient at blocking nor groove of DNA, were not able to abolish in vitro
transcription elongation by T7 RNA polymerase on atranscription than its linear counterpart, both in a cell-
free assay and in cells. These results confirm previously histone-free DNA [26]. Circularizing a TFO around its
DNA target represents a new way to increase triple helixpublished data showing that linear unmodified TFOs are
not strong inhibitors of transcription elongation, even stability to a level where the complex is almost irrevers-
ible without any covalent modification of the target. Thewhen they form stable triple helices [5, 6]. This may be
explained by the fact that the polymerase is able to stall circularization reaction is easy to carry out in vitro, and
may also be achieved by a chemical pathway [27; Roulonat the triplex site, and resume polymerization as soon
as the TFO dissociates. This dissociation may be en- et al., unpublished results]. Interestingly, this complex
can be reversed upon removal of the triplex-stabilizinghanced by the RNA polymerase [6]. Padlock oligonucle-
otide can lower the level of fully elongated RNA tran- agent. In addition to inhibition of gene expression, TFOs
have been used for several other purposes, such asscripts with efficiency up to 80%. With a total yield of
the padlock formation reaction of approximately 90%, transcriptional activation [28], activation of recombina-
tion [29], targeted gene modifications [30, 31], and as athis means that the inhibition is as strong as the one
observed with TFOs that have been crosslinked to their tool for studying DNA-associated functions, such as
DNA repair [22, 32, 33] and protein-DNA interactionstarget by a psoralen molecule (about 90%). These obser-
vations suggest that the lifetime of the complex between [9, 34, 35]. The ligand-modulated padlock oligonucleo-
tides described here with their specific features may bethe target and the padlock oligonucleotide is longer than
the lifetime of a complex formed with a linear oligonucle- used for such purposes.
Other applications may be thought of which wouldotide, or that the triple helix made by the padlock oligo-
nucleotide is less easily dissociated by the RNA poly- exploit further the concept described here. Endogenous
genes can be targeted by TFOs. There has been experi-merase. One can also postulate that it takes less time for
the dissociated padlock oligonucleotide to reassociate mental proof for the ability of TFOs to reach their target
within the nucleus [36] and to inhibit transcription factorwith its target than it takes for the polymerase to resume
its activity. In the absence of triplex stabilizing agent, binding as well as to arrest RNA synthesis [23, 37]. An
in vivo circularization method would introduce a topo-the padlock oligonucleotide may have slid away from
its binding site, but the RNA polymerase may also have logical link between a TFO and its target. It has been
reported that RNAs can be circularized around single-gone through the circular oligonucleotide or pushed it
to the end of the transcribed region. Single molecule stranded RNA targets by an autocatalytic mechanism
[38]. Triple helices can be formed with RNA as thirdexperiments may be used to answer this question.
Triplex-mediated inhibition of gene expression in cells strands [39, 40]. Our results point to the interest of
applying in vivo circularization methods for targetingrequires TFOs with a sufficient nuclease resistance and
binding strength under cellular conditions. Cellular stud- double-stranded DNA, which may result in improved
TFOs, the same way the circularizable antisense mole-ies are often performed with plasmid-harbored genes,
and triple helix is usually formed before transfection or cules are more efficient than linear ones. In gene ther-
apy, the expression of therapeutic transgenes must bemicroinjection of the plasmid by preincubation of the
plasmid with the TFO under favorable conditions [17– tightly controlled, for example by using tissue-specific
promoters. The constitutive expression of a transgene19]. Chemical modifications of the TFOs are always re-
quired for efficient inhibition of gene expression [3, 19] may have cytotoxic effects. Therefore, conditional gene
expression systems that can be temporally or spatiallyexcept for some G-rich oligos that form very stable triple
helices [4]. In some reported cases, covalent linking of regulated are of special interest. This control may be
achieved at the posttranscriptional level using low mo-the TFO to the target site was a requirement for inhibition
of gene expression [10, 11, 20]. The results we obtained lecular weight compounds [41, 42]. Provided the triplex
stabilizing agent can induce triple-helix formation in vivo,in cells may be explained by a better resistance of the
circular TFO to 3-exonucleases, and by the physical padlock-modified plasmids may offer a new method for
link between the plasmid and the TFO. But the results of the control of transgene expression by a small molecule.
the cell-free assay suggest that the enhanced inhibition
induced by circularizing the oligonucleotide could also
Significancebe due to the intramolecular nature of the complex,
or to steric reasons. Some triplex-mediated covalent
Circular oligonucleotides can be assembled aroundmodifications, such as DNA alkylation, are at least par-
specific double-stranded DNA sequences by using tri-tially repaired in cells [21]. Psoralen crosslinks seem to
ple-helix formation and an enzymatic circularizationbe much less efficiently repaired [10, 22]. It would be
reaction. Ligand-modulated padlock oligonucleotidesinteresting to investigate the interactions between pad-
have been previsouly shown to inhibit the cleavage oflock oligonucleotides and the DNA-repair machineries.
a plasmid by a restriction enzyme. In this study, theirThere are only a few reported examples of linear TFOs
effects on transcription elongation were investigated.that can inhibit elongation by RNA polymerases, either
Our results provide evidence for the sequence-spe-in vitro [5–8] or in cells [19, 23]. An efficient blockage of
transcription elongation was observed using PNA oligo- cific blocking of transcription elongation by padlock
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cooled to 37C. Then, 5 g of PvuII was added to the sample. Theoligonucleotides on plasmid-harbored genes. This
total volume was 20 L. Digestion was conducted for 2 hr at 37C.blockage was observed both in vitro and in live cells
Samples were mixed with 5l of 50% glycerol and loaded on nonde-that had been transfected with the padlock-modified
naturing polyacrylamide gels. The 6% polyacrylamide gel was pre-
plasmid. The padlock oligonucleotides were more effi- pared with a 29:1 acrylamide to bisacrylamide ratio. The gel and
cient than linear TFOs at inhibiting transcription elon- the buffer contained TBM (100 mM Tris, 90 mM boric acid, 1 mM
EDTA [pH 8.3], and 10 mM MgCl2). They were run at 4C, stainedgation by prokaryotic and eukaryotic RNA polymer-
for 15 min with SybrGreen (Molecular Probes), and imaged by UVases. This inhibition was observed only in the presence
transillumination. For the pRLCMV plasmid, the process was essen-of a triplex stabilizing agent. These results set the
tially the same except that 5 g of both AflIII and XmnI were usedbasis of new strategies for the in vitro formation of
instead of PvuII.
very stable triple helical DNA complexes that do not
involve covalent modification of the double-stranded In Vitro Transcription Assay
DNA target. They can be used for interfering efficiently 0.2 g of the pGA2 plasmid (modified or not with the padlock oligo-
nucleotide) was mixed in 5 l of 80 mM Tris-HCl (pH 7.5), 12 mMwith various DNA-related biological machineries, but
MgCl2, 20 mM NaCl, and 10 mM DTT. The final concentration ofalso pave the way for new artificial gene regulation
plasmid was 10 nM. In some samples, the linear TFO1 was addedmechanisms and single molecule studies.
so that the final concentration was 100 nM. One microliter of 200
M BQQ was added, the volume was brought to 8 l, the sample
Experimental Procedures was heated to 80C, and slowly cooled down to 37C. Then, the tubes
were transfered into ice and 1 l (5 units) of T3 RNA polymerase was
Plasmids, Oligonucleotides and Triple-Helix-Specific Ligand added. The transcription reaction was initiated by addition of 1 l
Plasmid pGA2, which was derived from pBluescript SKby insertion of the NTP mix (500 M ATP, CTP, UTP, 100 M GTP and 0.5 to 1
of a triplex target site in the multi-cloning-site (mcs), has already
Cie 32P-GTP). It was stopped after 15 min by ethanol precipitation.
been described [16]. Plasmids pRLCMV and pGL3c were obtained Samples were resuspended in a formamide loading buffer and ana-
from Promega. The sequences of the oligonucleotides used in this lyzed in a 8% denaturing polyacrylamide gel.
study are the following ones: 5-CGTACGGTCGACGCTAGCTTTTG
TTTGGTGTTGTGGGTTTTCACGTGGAGCTCGGATCC-3 for the 59-
Reporter Gene Expression in Mammalian Cellsmer triplex-forming oligonucleotide TFO1, 5-CGTACGGTCGTTTTTT
HeLa cells (ATCC HB 8056, Rockville, MA) were cultured in Dulbec-TTTTTTTGTGGTTGTTGTTTTTTTGCTCGGATCC-3 for the 50-mer
co’s modified Eagle’s medium (DMEM, Gibco) with 10% heat inacti-oligonucleotide TFO2, and 5-CGACCGTACGGGATCCG-3 for the
vated FBS. The culture medium was supplemented with nonessen-17-mer template oligonucleotide used in the circularization experi-
tial amino acids, 2 mM L-glutamine (Gibco), and antibiotics (100ments (see Figures 1 and 4). The sequence of the so-called TRAP
units/mL penicillin and 100 g/mL streptomycin). Cells were grownoligonucleotide, which forms an intramolecular triple helix and is
at 37C in a 5% CO2/air incubator. Padlock-modified pRLCMV plas-used to remove BQQ from the samples, is the following: 5-CTTTCCTTC
mid was prepared as described above, and treated as indicated forTCTCCTTTTTGGAGAGAAGGAAAGTTTTTGTTTGGTTGTGTGG-3.
removal of BQQ.All these oligonucleotides were obtained from Eurogentec (Seraing,
One day before the transfection assay, cells were harvested byBelgium). Their concentration was calculated using a nearest-neigh-
treatment with PET (PBS with 0.02% [w/v] EDTA and 2.5 g/mLbor model for absorption coefficients. Synthesis of the triplex stabi-
trypsin) at 37C for 5 min and resuspended in the culture mediumlizing agent BQQ (6-[3-(dimethylamino)propyl]amino-11-methoxy-
supplemented with 2 M of BQQ at 1.105 cells/mL. 96-well culturebenzo[f]quino-[3,4-b]quinoxaline) has been described elsewhere [43].
plates were then seeded with 100l per well (104 cells) of the suspen-TFO1 and TFO2 were 5-phosphorylated using the following pro-
sion of cells.tocol: 300 pmol of oligonucleotide were incubated in 50 l of T4
The polyamidodendrimer Superfect (Qiagen) was chosen for itsDNA ligase buffer (50 mM Tris-HCl, 10 mM MgCl2, 10 mM DTT, 1 mM ability to transfect efficiently many cell types in vitro. In order toATP, and 25 g/mL BSA [pH 7.8] at 25C, NEB) with 10 units T4
ensure triple-helix formation between the padlock oligonucleotidePNK, for 1 hr 30 min at 37C. The phosphorylated oligonucleotides
and its target sequence, the padlock-modified pRLCMV plasmidwere used without further purification.
(0.6 g) was first heated to 80C and slowly cooled down to 37C
in the presence of 66 M of BQQ in a total volume of 10 l of NEB
Padlock Formation 2 buffer. For control experiments, the unmodified pRLCMV plasmid
To assemble the padlock oligonucleotides and the plasmids, the was treated identically. Some control samples were heated in the
5-phosphorylated TFO (400 nM) was mixed with 200 nM (4 g in absence of BQQ. The treated plasmid was diluted in 20 l of cell
10 L) of plasmid and 20 M BQQ in T4 DNA ligase buffer. This culture medium devoid of serum and of antibiotics and mixed with
mixture was heated to 80C and slowly cooled down to 37C. Then, 3 g of Superfect in 20 l of the same medium. Cells were cotrans-
600 nM of the 17-mer oligonucleotide template and 133 units of fected with pGL3c which was used as a control for transfection
T4 DNA ligase (NEB) were added to achieve circularization of the efficiency. The pGL3c plasmid was prepared in parallel by mixing
oligonucleotide around the plasmid. 1.2 g of plasmid with 6 g of Superfect in a total volume of 60 l of
To remove BQQ from the triplex, the mixture (10 L) was first serum and antibiotic-free DMEM. In both cases, the Superfect:DNA
diluted to 50 l so that the final buffer concentration was 40 mM mass ratio was 5:1. Both formulations were gently mixed, kept 30
Tris-HCl (pH 8.0), 80 mM NaCl, 16 mM MgCl2, and 5 M TRAP min at room temperature and diluted with 115 l of culture medium
oligonucleotide. The samples were heated to 80C and then slowly containing serum and antibiotics. Complexes of pRLCMV (165 L)
cooled to 37C. Then, 50 l of 40 mM spermidine was added and were finally mixed with complexes of pGL3c (175 L). The final BQQ
the samples were left for 30 min at room temperature with frequent concentration was 1.94 M. Samples were vortexed briefly, cells
vortex mixing, in order to allow plasmid compaction. After centrifu- were washed with PBS, and 105 l of the coformulation was loaded
gation, the pellet was washed with 200 l of a solution containing onto the cells (three different wells with 0.2 g pRLCMV and 0.4 g
50% isopropanol, 10 mM MgCl2, 300 mM NaCl, and 25 mM EDTA pGL3c each). After 2 hr, the transfection medium was removed and
as previously described. This treatment resulted in complete elimi- replaced by culture medium supplemented with 2 M BQQ, and the
nation of the free oligonucleotides. Plasmid was resuspended in 20 cells were grown for 24 hr. For some experiments, the linear TFO2
l Tris-EDTA buffer (10 mM Tris [pH 8.0] and 1 mM EDTA). was added in the transfection medium at a final concentration of
1 M and the sample was heated to 80C, then slowly cooled down
to 37C.Gel-Shift Experiments
One microgram of pGA2 was diluted in NEB2 buffer (10 mM Tris- Firefly and Renilla luciferase activity were quantitated using the
dual-luciferase kit (Promega) according to the instructions of theHCl, 10 mM MgCl2, 1 mM dithiothreitol [pH 7.9] at 25C, and NEB)
containing 2 M BQQ. The samples were heated to 80C and slowly manufacturer. The cells were washed twice with PBS and lysed with
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50 l of cell lysis reagent for 30 min at room temperature, with gentle nucleotides for duplex DNA based on sequence-specific triple
helix formation. Proc. Natl. Acad. Sci. USA 96, 10603–10607.agitation. Luciferase expression was measured on 20 l of lysate
using the Luciferase Assay Reagent. Light emission was measured 13. Roulon, T., Coulaud, D., Delain, E., Lecam, E., He´le`ne, C., and
Escude´, C. (2002). Padlock oligonucleotides as a tool for label-by integration over 10 s using a multilabel counter Victor2 (EG&G
Wallac, Evry, France). Light emission was normalized to the protein ing superhelical DNA. Nucleic Acids Res. 30, e12.
14. Roulon, T., He´le`ne, C., and Escude´, C. (2002). Coupling targetingconcentration determined using the Biorad Protein Assay (Biorad).
Briefly, 250 l of a 5 dilution of the supplied dye reagent concen- peptides to supercoiled plasmids using a new type of padlock
oligonucleotide. Bioconjug. Chem. 13, 1134–1139.trate was added to 5 l of cell lysate and the absorbance at 595
nm was measured in 96-well microtiter plates using the multilabel 15. Ge´ron-Landre, B., Roulon, T., Desbiolles, P., and Escude´, C.
(2003). Sequence-specific fluorescent labeling of double-counter.
stranded DNA observed at the single molecule level. Nucleic
Acids Res. 31, e125.Acknowledgments
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